Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 16:10:1144692.
doi: 10.3389/fvets.2023.1144692. eCollection 2023.

β-mannanase supplementation in diets reduced in 85 kcal metabolizable energy/kg containing xylanase-phytase improves gain to feed ratio, nutrient usage, and backfat thickness in finisher pigs

Jansller Luiz Genova  1 , Paulo Evaristo Rupolo  2 , Liliana Bury de Azevedo  2 , Daniela Henz  2 , Silvana Teixeira Carvalho  2 , Marcos Kipper  3 , Giovana de Arruda Castelo Gonçalves  4 , Hellen Lazarino Oliveira Vilela  1 , Tiago Junior Pasquetti  4 , Newton Tavares Escocard de Oliveira  2 , Andrei Roberto Manelli Dietrich  2 , Paulo Levi de Oliveira Carvalho  2
Affiliations

β-mannanase supplementation in diets reduced in 85 kcal metabolizable energy/kg containing xylanase-phytase improves gain to feed ratio, nutrient usage, and backfat thickness in finisher pigs

Jansller Luiz Genova et al. Front Vet Sci. .

Abstract

This study aimed to assess the effects of β-mannanase supplementation in metabolizable energy (ME)-reduced diets containing xylanase-phytase on performance, fecal score, blood biochemical and immunological profile, apparent total tract digestibility (ATTD), digesta passage rate, fecal microbiome, carcass traits and meat quality in finisher pigs (n = 40 entire male hybrid, 26.0 ± 0.9 kg) randomly assigned to 1 of 4 dietary treatments: a control diet containing isolated phytase and xylanase valued at 40 kcal of ME/kg (CD0), CD0 + β-mannanase (0.3 g/kg valued at 30 kcal of ME/kg) (CD70), CD0 + β-mannanase (0.3 g/kg valued at 45 kcal of ME/kg) (CD85), and CD0 + β-mannanase (0.3 g/kg valued at 60 kcal of ME/kg) (CD100), with 10 pen replicates. Pigs fed CD0 diet showed (P = 0.002) greater ADFI. However, pigs fed CD0 diet showed (P = 0.009) lower G:F than those provided CD70 or CD85 diets. A greater (P < 0.001) superoxide dismutase concentration was observed in pigs fed CD70 diet. Pigs fed CD85 diet showed (P = 0.002) greater digestible protein than pigs fed CD0 or CD100 diets. Pigs fed CD70 diet showed an increase of 11.3% in digestible protein than those fed CD0 diet. In addition, greater (P < 0.001) digestible energy was observed in pigs fed CD85 diet. Pigs fed CD0 or CD100 diets showed greater (P < 0.05) Firmicutes:Bacteroidota ratio than those fed CD85 diet. The Muribaculaceae was more abundant (P = 0.030) in pigs fed CD70 diet than in those fed CD0 diet. The Prevotella was more abundant (P = 0.045) in pigs fed CD85 diet than in those fed CD100 diet. In conclusion, β-mannanase supplementation in diets containing xylanase-phytase allows reducing 85 kcal of ME/kg because it improves gain to feed ratio, energy and protein usage, and backfat thickness without metabolic and intestinal ecosystem disorders in finisher pigs.

Keywords: blood profile; carcass-meat traits; digestibility; exogenous enzymes; fecal microbiome; pig performance.

PubMed Disclaimer

Conflict of interest statement

MK was employed by Elanco Animal Health Incorporated Company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Alpha diversity estimated by parameters Chao1 (A), observed OTUs (B), Fisher (C), Simpson (D), Shannon (E), and Pielou (F) in finisher pigs fed 1 of 4 dietary treatments: a control diet containing isolated phytase and xylanase valued at 40 kcal of ME/kg (CD0), CD0 + β-mannanase (0.3 g/kg valued at 30 kcal of ME/kg) (CD70), CD0 + β-mannanase (0.3 g/kg valued at 45 kcal of ME/kg) (CD85), and CD0 + β-mannanase (0.3 g/kg valued at 60 kcal of ME/kg) (CD100). Data are averages of 6 pigs per dietary treatment.
Figure 2
Figure 2
Beta diversity estimated by parameters Bray-Curtis (A), Jaccard (B), Unifrac (C), and Weighted Unifrac (D) in finisher pigs fed 1 of 4 dietary treatments: a control diet containing isolated phytase and xylanase valued at 40 kcal of ME/kg (CD0), CD0 + β-mannanase (0.3 g/kg valued at 30 kcal of ME/kg) (CD70), CD0 + β-mannanase (0.3 g/kg valued at 45 kcal of ME/kg) (CD85), and CD0 + β-mannanase (0.3 g/kg valued at 60 kcal of ME/kg) (CD100). Data are averages of 6 pigs per dietary treatment.
Figure 3
Figure 3
Relative abundance of phyla (A), classes (B), orders (C), families (D), genera (E), and species (F) presents in finisher pigs fed 1 of 4 dietary treatments: a control diet containing isolated phytase and xylanase valued at 40 kcal of ME/kg (CD0), CD0 + β-mannanase (0.3 g/kg valued at 30 kcal of ME/kg) (CD70), CD0 + β-mannanase (0.3 g/kg valued at 45 kcal of ME/kg) (CD85), and CD0 + β-mannanase (0.3 g/kg valued at 60 kcal of ME/kg) (CD100). Data are averages of 6 pigs per dietary treatment.
Figure 4
Figure 4
Firmicutes:Bacteroidetes ratio in finisher pigs fed 1 of 4 dietary treatments: a control diet containing isolated phytase and xylanase valued at 40 kcal of ME/kg (CD0), CD0 + β-mannanase (0.3 g/kg valued at 30 kcal of ME/kg) (CD70), CD0 + β-mannanase (0.3 g/kg valued at 45 kcal of ME/kg) (CD85), and CD0 + β-mannanase (0.3 g/kg valued at 60 kcal of ME/kg) (CD100). Data are averages of 6 pigs per dietary treatment. Means differed by Wilcoxon test (P < 0.05).
Figure 5
Figure 5
Differential abundance analysis of taxon of the Muribaculaceae family in finisher pigs fed 1 of 4 dietary treatments: a control diet containing isolated phytase and xylanase valued at 40 kcal of ME/kg (CD0), CD0 + β-mannanase (0.3 g/kg valued at 30 kcal of ME/kg) (CD70), CD0 + β-mannanase (0.3 g/kg valued at 45 kcal of ME/kg) (CD85), and CD0 + β-mannanase (0.3 g/kg valued at 60 kcal of ME/kg) (CD100). Data are averages of 6 pigs per dietary treatment. Means differed by Wilcoxon test (P < 0.05).
Figure 6
Figure 6
Differential abundance analysis of taxon of the Prevotella genus in finisher pigs fed 1 of 4 dietary treatments: a control diet containing isolated phytase and xylanase valued at 40 kcal of ME/kg (CD0), CD0 + β-mannanase (0.3 g/kg valued at 30 kcal of ME/kg) (CD70), CD0 + β-mannanase (0.3 g/kg valued at 45 kcal of ME/kg) (CD85), and CD0 + β-mannanase (0.3 g/kg valued at 60 kcal of ME/kg) (CD100). Data are averages of 6 pigs per dietary treatment. Means differed by Wilcoxon test (P < 0.05).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Liu S, Ma C, Liu L, Ning D, Liu Y, Dong B. β-Xylosidase and β-mannosidase in combination improved growth performance and altered microbial profiles in weanling pigs fed a corn-soybean meal-based diet. Asian-Australas J Anim Sci. (2019) 32:1734. 10.5713/ajas.18.0873 - DOI - PMC - PubMed
    1. Vangroenweghe F, Poulsen K, Thas O. Supplementation of a β-mannanase enzyme reduces post-weaning diarrhea and antibiotic use in piglets on an alternative diet with additional soybean meal. Porc Health Manag. (2021) 7:1–12. 10.1186/s40813-021-00191-5 - DOI - PMC - PubMed
    1. Mok CH, Lee JH, Kim BG. Effects of exogenous phytase and β-mannanase on ileal and total tract digestibility of energy and nutrient in palm kernel expeller-containing diets fed to growing pigs. Anim Feed Sci Technol. (2013) 186:209–13. 10.1016/j.anifeedsci.2013.10.008 - DOI
    1. Tiwari UP, Chen H, Kim SW, Jha R. Supplemental effect of xylanase and mannanase on nutrient digestibility and gut health of nursery pigs studied using both in vivo and in vitro models. Anim Feed Sci Technol. (2018) 245:77–90. 10.1016/j.anifeedsci.2018.07.002 - DOI
    1. Kipper M, Andretta I, Quadros VRD, Schroeder B, Pires PGDS, Franceschina CS, França I. Performance responses of broilers and pigs fed diets with β-mannanase. Rev Bras Zootec. (2020) 49:1–11. 10.37496/rbz4920180177 - DOI - PubMed